Trillium’s Role in the Growing Hydrogen Market

Hydrogen is considered a greener and better alternative to other forms of gas energy production. It reduces emissions and can be produced from many sources, as opposed to only fossil fuels. The hydrogen market has a promising future but there are some key areas that need to be explored with its growth.

Where is the growth of the hydrogen market headed? And how are some companies in the industry contributing?

For this episode of “Flowcast,” host Michelle Dawn Mooney interviewed two team members of Trillium: Simon Bradshaw, Global Director of Engineering and Technology, and Sanket Walimbe, Technical Development Manager. The three discussed hydrogen, its value, some of the technical challenges in utilizing it, and how it can see wider adoption across the globe.

Mooney, Bradshaw, and Walimbe further talked about:

  1. Renewable energy and its rise
  2. The potential of the hydrogen market and its value chain givens its pros and cons
  3. The future of the hydrogen market

“The cost of hydrogen is still really high compared to other methods of producing it, but the main ones are gray and black hydrogen, or blue hydrogen, which are generally derived from fossil fuels. ‘Those costs for green hydrogen are likely to reduce significantly depending on innovation and all those things within the marketplace, but it’s currently still not cost competitive,” said Bradshaw.

Walimbe added that Trillium is best equipped in preparation for the growth of the hydrogen market.

“All I would say is that we have great intelligence on this topic within our business and product line, and it can also be compatible with the application with certain modifications, and with this in hand, we are keeping an eye on how the economy is taking shape in the future so we can adapt to it as we go on,” he said.

Simon Bradshaw is the Global Director of Engineering and Technology at Trillium. He’s been with the company for a year now, and was previously the Director of Engineering at Circor Industries Americas. Bradshaw has been in the engineering industry since 1986 and is a graduate of Heriot-Watt University and also holds credentials as a Chartered Engineer from the Institution of Engineering Designers.

Sanket Walimbe is the Technical Development Manager at Trillium. He’s been with the company for close to two years now and was previously the Principal Engineer at Trelleborg Group. Walimbe is a graduate of Alliance Manchester Business School and the University of Sheffield.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More